New portfolio enhancements reflect Bruker’s commitment to advancing integrated, high‑performance solutions that support laboratories in addressing evolving infectious disease challenges
Selected analytical systems and workflows based on mass spectrometry, NMR, SPR, X-ray analysis, nanoparticle tracking, and laboratory automation and software showcased in Hall A2, Booth 314
Novel glycoproteomics de novo workflows with timsOmni™ and OmniScape™ enable confident proteoform characterization
ProteoScape (PS) software integrates the Kuiper machine learning-enhanced search engine, for immunopeptides, and TagGraph for neoepitope discovery
FDA clearance of MBT FAST™ Shuttle US IVD and MBT Compass HT CA software improves workflow efficiency and accelerates data processing and FDA approval of expanded reference library increases coverage to 549 validated microbial species
Recognition underscores Bruker’s commitment to sustainability and innovation in microbial detection
Breakthrough Athena Ion Processor (AIP) delivers up to 35% more peptide and 20% more protein identifications for highest sensitivity proteomics
Enabling functional proteoform sequencing and post-translational modification (PTM) identification and localization with unprecedented depth and speed
Offering up to 50% improved peptide sensitivity, this technology further enhances robustness, sensitivity and proteome coverage in ultra-sensitive proteomics workflows
This collaboration aims to expand metabolite and lipid analysis through the power of mass spectrometry
Game-changing sensitivity for TIMS-enabled small molecule analysis
Bruker and RECIPE are pioneering the high-throughput ‘chrom-free’ ClinDART triple-quad MS platform for robust and cost-effective therapeutic drug monitoring assays
A compact benchtop optofluidic system with lower cost of ownership for broader research accessibility
In this guest editorial, Pascal Steffen-Lockhauserbäumer, Global Product Manager for timsTOF at Bruker Daltonics explores how spatial multiomics combines imaging with LC/MS to revolutionize biomolecular analysis, enabling high-resolution insights into disease mechanisms, immune response, and tissue structure, with applications in diagnostics and personalized medicine
